Search results
Results from the WOW.Com Content Network
This is a partial list of herbs and herbal treatments with known or suspected adverse effects, either alone or in interaction with other herbs or drugs. Non-inclusion of an herb in this list does not imply that it is free of adverse effects.
Bradycardia; Hypertension (high blood pressure); Allergic reactions (e.g. dyspnoea (shortness of breath), bronchospasm, wheezing, angioneurotic oedema) Anaphylaxis; Changes in appetite
Constipation. Dry mouth. Insomnia. ... Some of the most common drug interactions with weight loss pills are: ... Weight loss medications can affect the absorption or efficacy of thyroid hormone ...
Methylnaltrexone (MNTX, brand name Relistor), used in form of methylnaltrexone bromide (INN, USAN, BAN), is a medication that acts as a peripherally acting μ-opioid receptor antagonist that acts to reverse some of the side effects of opioid drugs such as constipation without significantly affecting pain relief or precipitating withdrawals.
It can be caused by certain drug interactions, as well as drinking alcohol while taking a medication like Lexapro. The signs and symptoms of Serotonin Syndrome include: Agitation or restlessness
Certain prokinetic drugs such as cisapride, renzapride and metoclopramide, although not 5-HT 3 antagonists proper, possess some weak antagonist effect at the 5-HT 3 receptor. Galanolactone , a diterpenoid found in ginger , is a 5-HT 3 antagonist and is believed to at least partially mediate the anti-emetic activity of this plant.
Naloxegol (INN; PEGylated naloxol; [4] trade names Movantik and Moventig) is a peripherally acting μ-opioid receptor antagonist developed by AstraZeneca, licensed from Nektar Therapeutics, for the treatment of opioid-induced constipation. [5] It was approved in 2014 in adult patients with chronic, non-cancer pain. [6]
Amiodarone has particularly important interactions with the following drugs: class I antiarrhythmics (amiodarone should not be combined with other class I antiarrhythmic drugs, such as disopyramide , flecainide , procainamide , quinidine , etc., due to an increased risk of QTc prolongation and potential arrhythmias); [ 13 ]